PharmInfoTech
Database of Oral Liquid Formulations

IMPORTANT Please read the disclaimer before using any of this information
All practitioners worldwide are welcome to use this information. If you have any suggestions, requests or comments please contact us.


Standardised formulations for New Zealand
: The Extemporaneous Compounding Pharmacists' Group in New Zealand has developed a list of standardised formulations (most of these currently use Ora Products) please refer to the overview document for an explanation of the rationale and process. This list will be continually reviewed and revised.
A collated file of individual batch sheets including compounding instructions for these formulations is now available.Individual batch sheets are being linked to the monographs in the eMixt monographs listed below. Until this process is complete (expected mid-September), pharmacists in New Zealand should refer to this collated file first.


Alphabetical Listing of Formulations

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

 

   
Acetazolamide  
Allopurinol
Amiloride
Aminophylline
Amiodarone
Amitriptyline
Amlodipine
Atenolol
Azathioprine
 
Baclofen
Bethanechol
Bromides (Triple) Mixture
Busulphan
 
Caffeine (citrated)
Carvedilol
Captopril
Carbamazepine
Carbidopa/levodopa
Cefuroxime
Chlorambucil
Chloroquine
Chlorothiazide
Ciprofloxacin
Clopidogrel
Clobazam                  New Information : September 2011
Clomipramine
Clonidine
Clozapine
Cortisone Acetate
 
Dantrolene
Dapsone
Dexamethasone
Diazepam
Diazoxide                   New Information : September 2011
Diltiazem
Dipyridamole
Disopyramide
Domperidone
 
Enalapril
Ethambutol
Etoposide
 
Famotidine
Flecainide                Standard batch Sheet now available
Fluconazole
Fludrocortisone
Fluoxetine
Folic Acid
Frusemide
 
Gabapentin
Ganciclovir
Griseofulvin
 
Hydrocortisone
Hydroxychloroquine
Hyoscine butyl bromide
Indomethacin
 
Isoniazid
Isradipine
Itraconazole
 

Labetalol

Lansoprazole
Levetiracetam
Levodopa/carbidopa
Levodopa/Carbidopa
Lithium Citrate
Lisinopril
Loperamide
 
Mercaptopurine
Methylphenidate
Metoclopramide New - updated May 2013
Metoprolol
Metronidazole
Midazolam
 
Naltrexone
Nifedipine
Nitrazepam
Nitrofurantoin
Norfloxacin
 
Olanzapine
Omeprazole
Ondansetron
 
Phenobarbitone/Phenobarbitone Sodium
Pilocarpine
Prednisone/Prednisolone Sodium
Procainamide
Procarbazine
Propranolol
Pyrazinamide
Pyrimethamine
 
Ranitidine
Rifampicin (Rifampin )
 
Sotalol
Sildenafil
Spironolactone
Sucralfate
Sulphadimidine
Sulphadiazine [JPPS Full Text] Formula under review/investgation 29 Jan 11
 
Tacrolimus
Terbinafine
Thiamine                 Formula currently under investigation. 31 Jan 11
Thyroxine
Tranexamic Acid
Trimethoprim          New Information : September 2011
 
Verapamil
Vigabatrin
 

Important Note

No person should rely on the contents of this database without first obtaining advice from a qualified professional person. This database is provided on the terms and understanding that the publisher, authors, consultants and editors are not responsible for the results of any actions taken on the basis of information in this database. The publisher, and the authors, consultants and editors, expressly disclaim all and any liability and responsibility to any person, whether a practitioner or reader of this publication or not, in respect of anything, and of the consequences of anything, done or omitted to be done by any such person in reliance, whether wholly or partially, upon the whole or any part of the contents of this database. Without limiting the generality of the above no author, consultant or editor shall have any responsibility for any act or omission of any author, consultant or editor. Inclusion of a formulation is not meant to imply that the editors or PharmInfoTech recommended the use of the formulation and/or drug either generally or for a specific condition. Some products listed may not necessarily be stocked in every hospital or country using this publication.